In addition, the Daley-Brown study, which demonstrated a relationship between leptin and increased aggressiveness and poor prognosis in patients with endometrial type II, where there is no obesity and diabetes appears to confirm the association of leptin with endometrial cancer regardless of associated diseases. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.